Correlation Between Cingulate Warrants and Enanta Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and Enanta Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and Enanta Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and Enanta Pharmaceuticals, you can compare the effects of market volatilities on Cingulate Warrants and Enanta Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of Enanta Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and Enanta Pharmaceuticals.
Diversification Opportunities for Cingulate Warrants and Enanta Pharmaceuticals
-0.47 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Cingulate and Enanta is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and Enanta Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enanta Pharmaceuticals and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with Enanta Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enanta Pharmaceuticals has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and Enanta Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cingulate Warrants and Enanta Pharmaceuticals
Assuming the 90 days horizon Cingulate Warrants is expected to generate 31.78 times more return on investment than Enanta Pharmaceuticals. However, Cingulate Warrants is 31.78 times more volatile than Enanta Pharmaceuticals. It trades about 0.13 of its potential returns per unit of risk. Enanta Pharmaceuticals is currently generating about -0.18 per unit of risk. If you would invest 0.90 in Cingulate Warrants on November 3, 2024 and sell it today you would earn a total of 4.35 from holding Cingulate Warrants or generate 483.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 98.4% |
| Values | Daily Returns |
Cingulate Warrants vs. Enanta Pharmaceuticals
Performance |
| Timeline |
| Cingulate Warrants |
| Enanta Pharmaceuticals |
Cingulate Warrants and Enanta Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cingulate Warrants and Enanta Pharmaceuticals
The main advantage of trading using opposite Cingulate Warrants and Enanta Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, Enanta Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enanta Pharmaceuticals will offset losses from the drop in Enanta Pharmaceuticals' long position.| Cingulate Warrants vs. Cingulate | Cingulate Warrants vs. Celularity | Cingulate Warrants vs. NeuroSense Therapeutics Ltd | Cingulate Warrants vs. Dermata Therapeutics Warrant |
| Enanta Pharmaceuticals vs. Monte Rosa Therapeutics | Enanta Pharmaceuticals vs. Design Therapeutics | Enanta Pharmaceuticals vs. Werewolf Therapeutics | Enanta Pharmaceuticals vs. Ikena Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |